Latest Breaking News On - Neurobo pharmaceuticals - Page 10 : comparemela.com

NeuroBo Pharmaceuticals (NRBO) Submits IND Application to the FDA for Phase 1 Trial of DA-1726

NeuroBo Pharmaceuticals (NRBO) Submits IND Application to the FDA for Phase 1 Trial of DA-1726
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Drug administrationNeurobo pharmaceuticals inc nasdaqNeurobo pharmaceuticalsInvestigational new drugIcheon kimChief executive officer

NeuroBo Pharmaceuticals Announces 1-for-8 Reverse Stock Split

NeuroBo Pharmaceuticals Announces 1-for-8 Reverse Stock Split
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMichael millerMarshallh woodworthCompany certificate of incorporationNeurobo pharmaceuticals incNeurobo pharmaceuticalsPrnewswire neurobo pharmaceuticals inc nasdaqDonga st coExchange commissionCompany common stockSplit adjusted basisCommon stockNasdaq capital marketNasdaq stock marketReverse stock splitInvestor relations

NeuroBo to Participate in Investor Conferences in December

BOSTON, Dec. 1, 2023 /PRNewswire/ NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases, today announced that Hyung.

United statesRobert homolkaMichael millerMarshallh woodworthPrnewswire neurobo pharmaceuticals incLife science virtual investor forumDonga st coNeurobo pharmaceuticalsRx communications groupNeurobo pharmaceuticals incHyung heon kimChief executive officerActing chief financial officerSenior vice presidentClinical operationsInvestor summit virtual

NeuroBo Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

DA-1726 Phase 1 IND Filing Expected by Year End 2023 Board Strengthened with Recent Appointment of Industry Veteran, James P. Tursi, M.D. Cash and Cash Equivalents of $25.8 Million, Expected to Fund.

United statesMarshall woodworthMichael millerZeid kayaliJamesp tursiDavid ramirezFund the company into fourth quarterNeurobo pharmaceuticalsDrug administrationEmpire liver foundationBoard nominating committeeDevelopment rd expensesMthera pharma co ltdNeurobo pharmaceuticals incRx communications groupDonga st co

NeuroBo Pharmaceuticals (NRBO) Appoints James P Tursi to its Board

NeuroBo Pharmaceuticals (NRBO) Appoints James P Tursi to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUrsinus collegeJamesp tursiAndrewi kovenNeurobo pharmaceuticals inc nasdaqAralez pharmaceuticals incClinical researchDevelopment for endo internationalCorporate governance committeeGlobal researchFerring pharmaceuticalsDevelopment for antares pharma incDevelopment for auxilium pharmaceuticals incCollege of pennsylvaniaProcter gamble pharmaceuticalsNeurobo pharmaceuticals